申请人:Hoelzemann Guenter
公开号:US20120101095A1
公开(公告)日:2012-04-26
Novel alkoxy-thienopyrimidine derivatives of formula (I)
wherein R
1
and R
2
have the meaning according to claim
1,
are inhibitors of TGF-beta receptor I kinase, and can be employed, inter alia, for the treatment of tumors.
式(I)的新型烷氧基噻唑嘧啶衍生物,其中R1和R2的含义根据权利要求1所述,是TGF-beta受体I激酶的抑制剂,可用于治疗肿瘤等疾病。